These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 12098934

  • 1. The role of dendritic cells in neurodegenerative diseases.
    Iribarren P, Cui YH, Le Y, Wang JM.
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):187-96. PubMed ID: 12098934
    [Abstract] [Full Text] [Related]

  • 2. Brain-immune connection: immuno-regulatory properties of CNS-resident cells.
    Becher B, Prat A, Antel JP.
    Glia; 2000 Feb 15; 29(4):293-304. PubMed ID: 10652440
    [Abstract] [Full Text] [Related]

  • 3. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.
    Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J.
    Cell Mol Immunol; 2005 Apr 15; 2(2):113-22. PubMed ID: 16191417
    [Abstract] [Full Text] [Related]

  • 4. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA, Mills KH.
    Brain Behav Immun; 2012 Jan 15; 26(1):1-10. PubMed ID: 21664452
    [Abstract] [Full Text] [Related]

  • 5. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L.
    Immunol Lett; 2005 Jan 15; 96(1):11-26. PubMed ID: 15585303
    [Abstract] [Full Text] [Related]

  • 6. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G, Banati R.
    Brain Res Brain Res Rev; 2004 Nov 15; 46(3):261-81. PubMed ID: 15571769
    [Abstract] [Full Text] [Related]

  • 7. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD, McMahon EJ, Schreiner B, Bailey SL.
    Ann N Y Acad Sci; 2007 Apr 15; 1103():179-91. PubMed ID: 17376826
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E, Mancardi G, Giunti D, Corcione A, Benvenuto F, Pistoia V, Uccelli A.
    Pharmacol Ther; 2006 Sep 15; 111(3):555-66. PubMed ID: 16442633
    [Abstract] [Full Text] [Related]

  • 9. MHC class II-associated invariant chain (Ii) modulates dendritic cells-derived microvesicles (DCMV)-mediated activation of microglia.
    Teo BH, Wong SH.
    Biochem Biophys Res Commun; 2010 Oct 01; 400(4):673-8. PubMed ID: 20816669
    [Abstract] [Full Text] [Related]

  • 10. Microglia, macrophages and the blood-brain barrier.
    Graeber MB.
    Clin Neuropathol; 1993 Oct 01; 12(5):296-7. PubMed ID: 8222403
    [No Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions.
    Hatterer E, Touret M, Belin MF, Honnorat J, Nataf S.
    PLoS One; 2008 Oct 02; 3(10):e3321. PubMed ID: 18830405
    [Abstract] [Full Text] [Related]

  • 12. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul 02; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

  • 13. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C, Martínez-Cáceres EM.
    Ann N Y Acad Sci; 2005 Jun 02; 1051():88-96. PubMed ID: 16126947
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells.
    Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F.
    J Neuropathol Exp Neurol; 2006 Feb 02; 65(2):124-41. PubMed ID: 16462204
    [Abstract] [Full Text] [Related]

  • 15. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS.
    Nature; 2002 Nov 07; 420(6911):78-84. PubMed ID: 12422218
    [Abstract] [Full Text] [Related]

  • 16. Is damage in central nervous system due to inflammation?
    Chavarria A, Alcocer-Varela J.
    Autoimmun Rev; 2004 Jun 07; 3(4):251-60. PubMed ID: 15246020
    [Abstract] [Full Text] [Related]

  • 17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M.
    Brain; 2005 Nov 07; 128(Pt 11):2689-704. PubMed ID: 16123145
    [Abstract] [Full Text] [Related]

  • 18. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 07; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 19. CNS dendritic cells: critical participants in CNS inflammation?
    McMahon EJ, Bailey SL, Miller SD.
    Neurochem Int; 2006 Jul 07; 49(2):195-203. PubMed ID: 16730862
    [Abstract] [Full Text] [Related]

  • 20. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED, Shriver LP, Maresz K, Dittel BN.
    J Neurosci Res; 2005 Aug 01; 81(3):374-89. PubMed ID: 15959904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.